Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.26 USD | -1.29% | +1.49% | +37.97% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.97% | 6.56B | |
+60.65% | 62.59B | |
-3.24% | 41.18B | |
+44.70% | 40.29B | |
-8.29% | 27.9B | |
+13.42% | 26.21B | |
-22.07% | 19.09B | |
+4.52% | 13.08B | |
+24.83% | 12.26B | |
+27.52% | 12.05B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Revolution Medicines' Price Target to $46 From $36, Keeps Buy Rating